This Week at FDA: Restructuring at inspections office, new guidances and staff, and more

After heavy criticism over the past year over its handling of the infant formula crisis, the US Food and Drug Administration (FDA) announced it is launching a new Human Foods Program and restructuring its Office of Regulatory Affairs (ORA), which conducts inspections of regulated products, sampling and reviews products entering the US. The agency has proposed a feedback loop structure for ORA that it says will help streamline inspection work across the various product centers.